This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Kratom (Mitragyna Speciosa)
Kratom is a tropical tree from Southeast Asia whose leaves contain alkaloids that interact with opioid receptors. At low doses it acts as a stimulant, while at higher doses it produces sedative and analgesic effects. Its legal status is contested in many countries, and it carries significant risks of dependence and withdrawal.
Benefits
What is Kratom (Mitragyna Speciosa)?
Kratom (Mitragyna speciosa) is a tropical evergreen tree in the Rubiaceae (coffee) family, native to Thailand, Malaysia, Indonesia, and Papua New Guinea. Its leaves have been used for centuries by indigenous populations as a traditional medicine and stimulant - labourers chewed fresh leaves to combat fatigue and increase productivity, while traditional healers used it for pain relief, diarrhoea, and opioid withdrawal.
The primary active alkaloids in kratom are mitragynine (constituting 60-66% of alkaloid content) and 7-hydroxymitragynine (a minor but highly potent constituent). These compounds interact with opioid receptors (mu, delta, and kappa) as well as adrenergic, serotonergic, and dopaminergic systems, producing a complex pharmacological profile that is dose-dependent.
Kratom occupies a controversial position in the nootropics world. At low doses (1-5 g of leaf), it produces stimulant-like effects including increased energy, alertness, and sociability. At higher doses (5-15 g), it produces opioid-like effects including sedation, pain relief, and euphoria. This dual nature, combined with its potential for dependence and its contested legal status, makes it one of the most debated substances in the cognitive enhancement community.
- Opioid receptor partial agonism: Mitragynine acts as a partial agonist at mu-opioid receptors and a competitive antagonist at kappa and delta receptors. 7-Hydroxymitragynine is a more potent mu-agonist. This accounts for the analgesic and mood-elevating effects.
- Adrenergic stimulation (low dose): At lower doses, mitragynine activates alpha-2 adrenergic receptors and inhibits norepinephrine reuptake, producing stimulant effects similar to mild amphetamines.
- Serotonergic activity: Kratom alkaloids interact with serotonin receptors (5-HT2A and 5-HT2C), contributing to mood modulation and potential antidepressant effects.
- Dopaminergic effects: Interaction with dopamine D1 and D2 receptors may contribute to the motivation-enhancing and euphoric effects, as well as addiction potential.
- Dose-dependent profile: Low doses favour adrenergic/stimulant pathways. Higher doses increasingly engage opioid pathways, shifting effects from stimulation to sedation and analgesia.
- Low/stimulant dose: 1-3 g of dried leaf powder
- Moderate dose: 3-5 g (mixed stimulant/sedative effects)
- High/sedative dose: 5-8 g (predominantly opioid-like effects)
- Very high dose: 8+ g (strong sedation - not recommended due to increased side effects and dependency risk)
- Strain variations: "White" strains are considered more stimulating, "red" more sedating, and "green" moderate. These distinctions may relate to leaf maturity and drying methods.
CAUTION: Kratom carries genuine risk of dependence with regular use. If used at all, limit frequency strictly. Daily use is strongly discouraged. Start with the lowest effective dose.
- DEPENDENCE AND WITHDRAWAL: Regular kratom use (especially daily use) can lead to physical dependence. Withdrawal symptoms include irritability, muscle aches, insomnia, nausea, sweating, and mood disturbances - similar to mild opioid withdrawal.
- Legal status: Kratom is banned in Thailand (though recently decriminalised), Australia, several EU countries, and some US states. Check local laws before purchasing.
- Contamination risk: Unregulated kratom products have been found contaminated with heavy metals, salmonella, and other adulterants. Quality control is a serious concern.
- Liver toxicity: Rare but documented cases of liver injury have been reported with kratom use, particularly with concentrated extracts.
- Drug interactions: May interact dangerously with opioids, benzodiazepines, alcohol, MAOIs, and other CNS depressants. Combining kratom with other sedatives has been associated with fatalities.
- Pregnancy: Absolutely avoid during pregnancy. Neonatal abstinence syndrome has been reported in infants born to regular kratom users.
Natural Sources & Forms
- Dried leaf powder: The most common form, available from online vendors in various "strains"
- Capsules: Pre-measured dried leaf powder in gelatin or vegetable capsules
- Extracts: Concentrated forms (liquid or powder) - significantly more potent and higher risk
- Fresh leaves: Traditionally chewed in Southeast Asia, not available in most Western countries
- Tea: Dried leaves brewed as tea, a traditional method of consumption
Frequently Asked Questions
Kratom is a tropical tree from Southeast Asia whose leaves contain alkaloids that interact with opioid receptors. At low doses it acts as a stimulant, while at higher doses it produces sedative and analgesic effects. Its legal status is contested in many countries, and it carries significant risks of dependence and withdrawal.
The key benefits of Kratom (Mitragyna Speciosa) include: Anxiety & Calm, Energy, Focus, Mood, Motivation, Stress Relief.
Opioid receptor partial agonism: Mitragynine acts as a partial agonist at mu-opioid receptors and a competitive antagonist at kappa and delta receptors. 7-Hydroxymitragynine is a more potent mu-agonist. This accounts for the analgesic and mood-elevating effects. Adrenergic stimulation (low dose): At lower doses, mitragynine activates alpha-2 adrenergic receptors and inhibits norepinephrine reuptake, producing stimulant effects similar to mild amphetamines. Serotonergic activity: Kratom alkaloids interact with serotonin receptors (5-HT2A and 5-HT2C), contributing to mood modulation and potential antidepressant effects. Dopaminergic effects: Interaction with dopamine D1 and D2 receptors may contribute to the motivation-enhancing and euphoric effects, as well as addiction potential. Dose-dependent profile: Low doses favour adrenergic/stimulant pathways. Higher doses increasingly engage opioid pathways, shifting effects from stimulation to sedation and analgesia.
Low/stimulant dose: 1-3 g of dried leaf powder Moderate dose: 3-5 g (mixed stimulant/sedative effects) High/sedative dose: 5-8 g (predominantly opioid-like effects) Very high dose: 8+ g (strong sedation - not recommended due to increased side effects and dependency risk) Strain variations: "White" strains are considered more stimulating, "red" more sedating, and "green" moderate. These distinctions may relate to leaf maturity and drying methods. CAUTION: Kratom carries genuine risk of dependence with regular use. If used at all, limit frequency strictly. Daily use is strongly discouraged. Start with the lowest effective dose.
DEPENDENCE AND WITHDRAWAL: Regular kratom use (especially daily use) can lead to physical dependence. Withdrawal symptoms include irritability, muscle aches, insomnia, nausea, sweating, and mood disturbances - similar to mild opioid withdrawal. Legal status: Kratom is banned in Thailand (though recently decriminalised), Australia, several EU countries, and some US states. Check local laws before purchasing. Contamination risk: Unregulated kratom products have been found contaminated with heavy metals, salmonella, and other adulterants. Quality control is a serious concern. Liver toxicity: Rare but documented cases of liver injury have been reported with kratom use, particularly with concentrated extracts. Drug interactions: May interact dangerously with opioids, benzodiazepines, alcohol, MAOIs, and other CNS depressants. Combining kratom with other sedatives has been associated with fatalities. Pregnancy: Absolutely avoid during pregnancy. Neonatal abstinence syndrome has been reported in infants born to regular kratom users.
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!